Acasti PharmaACST
About: Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.
Employees: 4
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
45% more capital invested
Capital invested by funds: $4.34M [Q1] → $6.3M (+$1.96M) [Q2]
20% more funds holding
Funds holding: 10 [Q1] → 12 (+2) [Q2]
9.42% more ownership
Funds ownership: 13.48% [Q1] → 22.9% (+9.42%) [Q2]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
HC Wainwright & Co. Oren Livnat 70% 1-year accuracy 16 / 23 met price target | 279%upside $12 | Buy Reiterated | 26 Sept 2024 |
Craig-Hallum Chase Knickerbocker 48% 1-year accuracy 10 / 21 met price target | 152%upside $8 | Buy Maintained | 26 Sept 2024 |
